Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rosuvastatin and Melatonin Creams vs Placebo in Mild to Moderate Plaque Psoriasis
IRCT20190810044500N16Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in plaque psoriasis comparing Topical melatonin cream, Topical rosuvastatin cream and Placebo cream (3 arms). Primary endpoints: Psoriasis Area Severity Index (PASI), Dermatological Sum Score (DSS) and 1 more. Started Apr 2021; status: completed.
02
Drugs
melatoninrosuvastatin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on IRCT20190810044500N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190810044500N16.